WCBA
CC icon

Weaver C. Barksdale & Associates’s Chemours CC Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$34K Buy
688
+82
+14% +$4.29K 0.04% 119
2017
Q3 		$31K Sell
606
-178
-23% -$8.4K 0.03% 119
2017
Q2 		$30K Sell
784
-25
-3% -$986 0.04% 123
2017
Q1 		$31K Buy
+809
New +$24.3K 0.04% 120
2016
Q1 		– Sell
-4,709
Closed -$25K – 548
2015
Q4 		$25K Buy
4,709
+1,777
+61% +$11.4K 0.02% 136
2015
Q3 		$19K Buy
+2,932
New +$30.7K 0.02% 159

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Weaver C. Barksdale & Associates's CC Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Chemours (CC) stake by 14% in Q4 2017, buying an estimated $4.29K and bringing the position to 688 shares worth $34K. The position accounts for 0.04% of the portfolio, ranked #119.

Weaver C. Barksdale & Associates first reported a position in CC in Q3 2015 and has held it in 6 quarters since. 538 funds tracked by Wall St. Rank hold CC as of Q4 2017.

  • Weaver C. Barksdale & Associates held 688 shares of Chemours worth $34K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 82 Chemours shares in Q4 2017, an estimated $4.29K.
  • Chemours made up 0.04% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #119 holding.
  • Weaver C. Barksdale & Associates first reported a position in Chemours in Q3 2015 and has held it in 6 quarters since.
  • 538 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.